Cancer researchers at the Faculty of Medicine and Health have made major contributions to the study of the disease, from fundamental cell biology to treatment, control, supportive care and rehabilitation.
Our researchers run major programs looking at the causes of cancer, including the impact of cancer-causing agents such as chemicals, radiation, viruses and human behaviour. We also run programs examining biological factors that can reduce or increase cancer risk, such as inflammation and DNA damage.
The University’s cancer research programs focus on clinical and translational excellence. Our current NHMRC grants highlight cancer prevention and screening, cancer genetics, and the development of new drug, cell and radiation treatments, with application in a wide number of cancers including leukaemia, melanoma, cervical, liver and breast cancer.
We're in a unique position to tackle cancer research through our multidisciplinary network of schools, centres and facilities.
Learn more about research at the Sydney Medical School.
Our cancer researchers are using cell biology and other methods to investigate the mechanisms that regulate cell proliferation and differentiation. This general approach is applied to understanding basic cell physiology, cancer biology, developmental biology and the pathogenesis of infectious diseases.
Learn more about cancer research at the Bosch Institute.
Learn more about research at the School of Medical Sciences.
Our research aims to increase nurses' specialist knowledge as they support people and their families during and after cancer treatments.
Partly funded by the Cancer Institute NSW, the Cancer Nursing Research Unit is a consortium of the Sydney Nursing School, University of Sydney and the Chris O'Brien Lifehouse. This brings together Sydney Nursing School's strength in cancer and palliative care research and the Chris O'Brien Lifehouse's reputation as a centre of excellence in clinical cancer care.
The Cancer Nursing Research Unit leads research in cancer and supportive care and supports cancer and palliative care nurses across NSW to develop their research capacity and skills.
Research is conducted under four broad themes:
Learn more about research in the Sydney Nursing School.
Learn more about research at the Sydney Pharmacy School.
Our Cancer Epidemiology and Prevention Research Group conducts research on cancer etiology, prevention, early detection and survivorship, with particular focus on skin cancer and a strong emphasis on translational outcomes relevant to cancer control policy and clinical practice.
Our expertise is in quantitative and qualitative research design, as well as observational, intervention and data linkage studies. We have strong national and international multidisciplinary engagement including collaborations with clinicians, health economists, psychologists, sociologists, bioethicists, geneticists, laboratory scientists and others.
Learn more about research at Sydney School of Public Health.
Research in cancer at the Sydney School of Health Sciences is transforming knowledge and making an impact upon clinical practice in areas such as early diagnosis, treatment of the disease and its side-effects, and the development of novel pharmaceuticals that can diagnose and treat cancer at the same time.
Our international leaders in cancer research are improving diagnosis by using novel imaging techniques and new technologies. In rehabilitation, we are challenging long-held beliefs about problems arising from cancer treatment, developing better interventions, and treating the consequences of medical intervention.
Learn more about research at the Sydney School of Health Sciences.
Comments are now invited during the current period of public consultation for the ‘Clinical Practice Guidelines for the Management of Communication and Swallowing in Children diagnosed with Childhood Brain Tumour or Leukaemia: Draft for Public Consultation (July 13, 2020) (pdf, 2.4mb).
Public consultation is now open for 30 days, commencing July 13, 2020. Any comments can be sent to the Chair of the Guideline Development Committee, Dr Kimberley Docking.
Please note: This draft manuscript is strictly for review purposes only during the 30-day public consultation period starting July 13, 2020. It is not to be used or distributed as the final version.
The Guideline is currently undergoing a period of public consultation and review as part of NHMRC’s approval processes, and changes to the content are anticipated once the consultation and review periods have concluded.
A final published version will be made available in November 2020.